How effective is Robaxin for Arthritis ?


Summary

3 Robaxin users have rated its effectiveness for Arthritis.

Overall ratings: 2.3/5
Long term ratings: 0/5

This is a reivew of how effective Robaxin (methocarbamol) is for Arthritis and for what kind of people. The study is created by eHealthMe and is updated continuously.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jul, 16, 2017

3 people are studied for taking Robaxin in Arthritis


Overall effectiveness (number of people)

Does Robaxin work for your Arthritis (overall)?

Long term effectiveness (number of people)

Does Robaxin work for your Arthritis (long term)?

Robaxin effectiveness for Arthritis (number of people)

Overall:
  • not at all: 0
  • somewhat: 2
  • moderate: 1
  • high: 0
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 0
  • high: 0
  • very high: 0

Gender of people who take Robaxin for Arthritis *

  • female: 100 %
  • male: 0.0 %

Age of people who take Robaxin for Arthritis *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 33.33 %
  • 60+: 0.0 %

Who finds Robaxin more effective for Arthritis?


* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

Robaxin

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. (latest outcomes from Robaxin 4,916 users)

Arthritis

Arthritis (form of joint disorder that involves inflammation of one or more joints) has been reported by people with rheumatoid arthritis, osteoporosis, multiple sclerosis, high blood pressure, high blood cholesterol (latest reports from 91,537 Arthritis patients).

Related studies: